FindTrial
Sign In

volumetric MRI

DIAGNOSTIC_TEST2 trials

Sponsors

Amoneta Diagnostics SAS, Universitaire Ziekenhuizen KU Leuven

Conditions

Alzheimer Disease (AD)Corticobasal Degeneration (CBD)Dementia with Lewy Bodies (DLB)Frontotemporal Lobar DegenerationHuntington DiseaseParkinson Disease Dementia (PDD)Progressive Supranuclear Palsy (PSP)

Unknown Phase

ADDIA Proof-of-Performance Clinical Study
CompletedNCT03030586
Amoneta Diagnostics SASAlzheimer Disease (AD), Corticobasal Degeneration (CBD), Dementia with Lewy Bodies (DLB) +3
Start: 2016-09-01End: 2023-06-30Updated: 2024-09-19
Longitudinal SV2A PET and MRI in Premanifest HD
Active, not recruitingNCT06626412
Universitaire Ziekenhuizen KU LeuvenHuntington Disease
Start: 2024-12-04End: 2028-12-31Target: 40Updated: 2026-05-05

Related Papers

Metabolomic Signatures and Machine Learning Models for Distinguishing Alzheimer's Disease and Dementia with Lewy Bodies
Alzheimer s & Dementia2025-12-011 citations
Metabolomic Signatures and Machine Learning Models for Distinguishing Alzheimer's Disease and Dementia with Lewy Bodies
Alzheimer s & Dementia2025-12-01